-
1
-
-
0035084699
-
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
-
Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML and Clore JN: Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120: 1183-1192, 2001.
-
(2001)
Gastroenterology
, vol.120
, pp. 1183-1192
-
-
Sanyal, A.J.1
Campbell-Sargent, C.2
Mirshahi, F.3
Rizzo, W.B.4
Contos, M.J.5
Sterling, R.K.6
Luketic, V.A.7
Shiffman, M.L.8
Clore, J.N.9
-
2
-
-
0036829092
-
AGA technical review on nonalcoholic fatty liver disease
-
American Gastroenterological Association
-
Sanyal AJ; American Gastroenterological Association: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123: 1705-1725, 2002.
-
(2002)
Gastroenterology
, vol.123
, pp. 1705-1725
-
-
Sanyal, A.J.1
-
4
-
-
10644220306
-
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
-
Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM and Hobbs HH: Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395, 2004.
-
(2004)
Hepatology
, vol.40
, pp. 1387-1395
-
-
Browning, J.D.1
Szczepaniak, L.S.2
Dobbins, R.3
Nuremberg, P.4
Horton, J.D.5
Cohen, J.C.6
Grundy, S.M.7
Hobbs, H.H.8
-
5
-
-
84877854022
-
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
-
Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E and Gastaldelli A: Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5: 1544-1560, 2013.
-
(2013)
Nutrients
, vol.5
, pp. 1544-1560
-
-
Gaggini, M.1
Morelli, M.2
Buzzigoli, E.3
DeFronzo, R.A.4
Bugianesi, E.5
Gastaldelli, A.6
-
6
-
-
78650486196
-
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study
-
Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL and Harrison SA: Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140: 124-131, 2011.
-
(2011)
Gastroenterology
, vol.140
, pp. 124-131
-
-
Williams, C.D.1
Stengel, J.2
Asike, M.I.3
Torres, D.M.4
Shaw, J.5
Contreras, M.6
Landt, C.L.7
Harrison, S.A.8
-
7
-
-
77952563455
-
Liver fat in the pathogenesis of insulin resistance and type 2 diabetes
-
Yki-Jarvinen H: Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig Dis 28: 203-209, 2010.
-
(2010)
Dig Dis
, vol.28
, pp. 203-209
-
-
Yki-Jarvinen, H.1
-
8
-
-
70349326750
-
Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity
-
Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A and Klein S: Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 106: 15430-15435, 2009.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 15430-15435
-
-
Fabbrini, E.1
Magkos, F.2
Mohammed, B.S.3
Pietka, T.4
Abumrad, N.A.5
Patterson, B.W.6
Okunade, A.7
Klein, S.8
-
9
-
-
25644448266
-
Fat in the liver and insulin resistance
-
Yki-Jarvinen H: Fat in the liver and insulin resistance. Ann Med 37: 347-356, 2005.
-
(2005)
Ann Med
, vol.37
, pp. 347-356
-
-
Yki-Jarvinen, H.1
-
10
-
-
0033305213
-
Peroxisome proliferator-activated receptors: Nuclear control of metabolism
-
Desvergne B and Wahli W: Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20: 649-688, 1999.
-
(1999)
Endocr Rev
, vol.20
, pp. 649-688
-
-
Desvergne, B.1
Wahli, W.2
-
11
-
-
0032489437
-
Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)
-
Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T and Gonzalez FJ: Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 273: 5678-5684, 1998.
-
(1998)
J Biol Chem
, vol.273
, pp. 5678-5684
-
-
Aoyama, T.1
Peters, J.M.2
Iritani, N.3
Nakajima, T.4
Furihata, K.5
Hashimoto, T.6
Gonzalez, F.J.7
-
12
-
-
10144234128
-
Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene
-
Fan CY, Pan J, Chu R, Lee D, Kluckman KD, Usuda N, Singh I, Yeldandi AV, Rao MS, Maeda N and Reddy JK: Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J Biol Chem 271: 24698-24710, 1996.
-
(1996)
J Biol Chem
, vol.271
, pp. 24698-24710
-
-
Fan, C.Y.1
Pan, J.2
Chu, R.3
Lee, D.4
Kluckman, K.D.5
Usuda, N.6
Singh, I.7
Yeldandi, A.V.8
Rao, M.S.9
Maeda, N.10
Reddy, J.K.11
-
13
-
-
0033594980
-
A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: The PPARalpha-null mouse as a model of fatty acid oxidation disorders
-
Leone TC, Weinheimer CJ and Kelly DP: A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 96: 7473-7478, 1999.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 7473-7478
-
-
Leone, T.C.1
Weinheimer, C.J.2
Kelly, D.P.3
-
14
-
-
0028641559
-
Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
-
Tontonoz P, Hu E and Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79: 1147-1156, 1994.
-
(1994)
Cell
, vol.79
, pp. 1147-1156
-
-
Tontonoz, P.1
Hu, E.2
Spiegelman, B.M.3
-
15
-
-
0037330414
-
PPARgamma agonists in the treatment of type II diabetes: Is increased fatness commensurate with long-term efficacy?
-
Larsen TM, Toubro S and Astrup A: PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy? Int J Obes Relat Metab Disord 27: 147-161, 2003.
-
(2003)
Int J Obes Relat Metab Disord
, vol.27
, pp. 147-161
-
-
Larsen, T.M.1
Toubro, S.2
Astrup, A.3
-
16
-
-
37249059359
-
PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes
-
Seo YS, Kim JH, Jo NY, Choi KM, Baik SH, Park JJ, Kim JS, Byun KS, Bak YT, Lee CH, et al: PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes. J Gastroenterol Hepatol 23: 102-109, 2008.
-
(2008)
J Gastroenterol Hepatol
, vol.23
, pp. 102-109
-
-
Seo, Y.S.1
Kim, J.H.2
Jo, N.Y.3
Choi, K.M.4
Baik, S.H.5
Park, J.J.6
Kim, J.S.7
Byun, K.S.8
Bak, Y.T.9
Lee, C.H.10
-
18
-
-
0034804726
-
Pioglitazone: Mechanism of action
-
Smith U: Pioglitazone: mechanism of action. Int J Clin Pract Suppl: 13-18, 2001.
-
(2001)
Int J Clin Pract Suppl
, vol.13-18
-
-
Smith, U.1
-
19
-
-
0033542873
-
Medical significance of peroxisome proliferator-activated receptors
-
Vamecq J and Latruffe N: Medical significance of peroxisome proliferator-activated receptors. Lancet 354: 141-148, 1999.
-
(1999)
Lancet
, vol.354
, pp. 141-148
-
-
Vamecq, J.1
Latruffe, N.2
-
20
-
-
0141532275
-
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone
-
Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D and Bacon BR: Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 38: 1008-1017, 2003.
-
(2003)
Hepatology
, vol.38
, pp. 1008-1017
-
-
Neuschwander-Tetri, B.A.1
Brunt, E.M.2
Wehmeier, K.R.3
Oliver, D.4
Bacon, B.R.5
-
21
-
-
84891922735
-
Peroxisome proliferator-activated receptor gamma regulates genes involved in insulin/insulin-like growth factor signaling and lipid metabolism during adipogenesis through functionally distinct enhancer classes
-
Oger F, Dubois-Chevalier J, Gheeraert C, Avner S, Durand E, Froguel P, Salbert G, Staels B, Lefebvre P and Eeckhoute J: Peroxisome proliferator-activated receptor gamma regulates genes involved in insulin/insulin-like growth factor signaling and lipid metabolism during adipogenesis through functionally distinct enhancer classes. J Biol Chem 289: 708-722, 2014.
-
(2014)
J Biol Chem
, vol.289
, pp. 708-722
-
-
Oger, F.1
Dubois-Chevalier, J.2
Gheeraert, C.3
Avner, S.4
Durand, E.5
Froguel, P.6
Salbert, G.7
Staels, B.8
Lefebvre, P.9
Eeckhoute, J.10
-
22
-
-
77950202392
-
Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells
-
Coll T, Alvarez-Guardia D, Barroso E, Gómez-Foix AM, Palomer X, Laguna JC and Vázquez-Carrera M: Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells. Endocrinology 151: 1560-1569, 2010.
-
(2010)
Endocrinology
, vol.151
, pp. 1560-1569
-
-
Coll, T.1
Alvarez-Guardia, D.2
Barroso, E.3
Gómez-Foix, A.M.4
Palomer, X.5
Laguna, J.C.6
Vázquez-Carrera, M.7
-
23
-
-
79955368052
-
The PPARbeta/delta activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1alpha-Lipin 1-PPARalpha pathway leading to increased fatty acid oxidation
-
Barroso E, Rodriguez-Calvo R, Serrano-Marco L, Astudillo AM, Balsinde J, Palomer X and Vázquez-Carrera M: The PPARbeta/delta activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1alpha-Lipin 1-PPARalpha pathway leading to increased fatty acid oxidation. Endocrinology 152: 1848-1859, 2011.
-
(2011)
Endocrinology
, vol.152
, pp. 1848-1859
-
-
Barroso, E.1
Rodriguez-Calvo, R.2
Serrano-Marco, L.3
Astudillo, A.M.4
Balsinde, J.5
Palomer, X.6
Vázquez-Carrera, M.7
-
24
-
-
84856705923
-
The peroxisome proliferator-activated receptor (PPAR) beta/delta agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells
-
Serrano-Marco L, Barroso E, El Kochairi I, Palomer X, Michalik L, Wahli W and Vázquez-Carrera M: The peroxisome proliferator-activated receptor (PPAR) beta/delta agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells. Diabetologia 55: 743-751, 2012.
-
(2012)
Diabetologia
, vol.55
, pp. 743-751
-
-
Serrano-Marco, L.1
Barroso, E.2
El Kochairi, I.3
Palomer, X.4
Michalik, L.5
Wahli, W.6
Vázquez-Carrera, M.7
-
25
-
-
33645891166
-
Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet
-
Nagasawa T, Inada Y, Nakano S, Tamura T, Takahashi T, Maruyama K, Yamazaki Y, Kuroda J and Shibata N: Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet. Eur J Pharmacol 536: 182-191, 2006.
-
(2006)
Eur J Pharmacol
, vol.536
, pp. 182-191
-
-
Nagasawa, T.1
Inada, Y.2
Nakano, S.3
Tamura, T.4
Takahashi, T.5
Maruyama, K.6
Yamazaki, Y.7
Kuroda, J.8
Shibata, N.9
-
26
-
-
0021813187
-
Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
-
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
-
(1985)
Diabetologia
, vol.28
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
Naylor, B.A.4
Treacher, D.F.5
Turner, R.C.6
-
27
-
-
63449137682
-
Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease
-
Wang HN, Wang YR, Liu GQ, Liu Z, Wu PX, Wei XL and Hong TP: Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease. World J Gastroenterol 14: 7240-7246, 2008.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 7240-7246
-
-
Wang, H.N.1
Wang, Y.R.2
Liu, G.Q.3
Liu, Z.4
Wu, P.X.5
Wei, X.L.6
Hong, T.P.7
-
28
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
-
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
-
(2001)
Methods
, vol.25
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
29
-
-
77957302090
-
Hepatic steatosis: A role for de novo lipogenesis and the transcription factor SREBP-1c
-
Ferre P and Foufelle F: Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 12 (Suppl 2): S83-S92, 2010.
-
(2010)
Diabetes Obes Metab
, vol.12
, pp. S83-S92
-
-
Ferre, P.1
Foufelle, F.2
-
30
-
-
0033544940
-
Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes
-
Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K, Harada K, et al: Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 274: 35832-35839, 1999.
-
(1999)
J Biol Chem
, vol.274
, pp. 35832-35839
-
-
Shimano, H.1
Yahagi, N.2
Amemiya-Kudo, M.3
Hasty, A.H.4
Osuga, J.5
Tamura, Y.6
Shionoiri, F.7
Iizuka, Y.8
Ohashi, K.9
Harada, K.10
-
31
-
-
0027447461
-
Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers
-
Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K and Wahli W: Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA 90: 2160-2164, 1993.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 2160-2164
-
-
Keller, H.1
Dreyer, C.2
Medin, J.3
Mahfoudi, A.4
Ozato, K.5
Wahli, W.6
-
32
-
-
0027275024
-
Peroxisome proliferator-activated receptors and lipid metabolism
-
Keller H, Mahfoudi A, Dreyer C, Hihi AK, Medin J, Ozato K and Wahli W: Peroxisome proliferator-activated receptors and lipid metabolism. Ann NY Acad Sci 684: 157-173, 1993.
-
(1993)
Ann NY Acad Sci
, vol.684
, pp. 157-173
-
-
Keller, H.1
Mahfoudi, A.2
Dreyer, C.3
Hihi, A.K.4
Medin, J.5
Ozato, K.6
Wahli, W.7
-
33
-
-
0027139820
-
Peroxisome proliferator-activated receptors A link between endocrinology and nutrition?
-
Keller H and Wahli W: Peroxisome proliferator-activated receptors A link between endocrinology and nutrition? Trends Endocrinol Metab 4: 291-296, 1993.
-
(1993)
Trends Endocrinol Metab
, vol.4
, pp. 291-296
-
-
Keller, H.1
Wahli, W.2
-
34
-
-
0006132932
-
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
-
Kliewer SA, Sundseth SS, Jones SA,Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM and Lehmann JM: Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94: 4318-4323, 1997.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 4318-4323
-
-
Kliewer, S.A.1
Sundseth, S.S.2
Jones, S.A.3
Brown, P.J.4
Wisely, G.B.5
Koble, C.S.6
Devchand, P.7
Wahli, W.8
Willson, T.M.9
Lenhard, J.M.10
Lehmann, J.M.11
-
35
-
-
0030952937
-
Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
-
Forman BM, Chen J and Evans RM: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 94: 4312-4317, 1997.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 4312-4317
-
-
Forman, B.M.1
Chen, J.2
Evans, R.M.3
-
36
-
-
33644766913
-
PPARdelta regulates glucose metabolism and insulin sensitivity
-
Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, Gonzalez FJ, Ham J, Kang H, Peters JM and Evans RM: PPARdelta regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci USA 103: 3444-3449, 2006.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 3444-3449
-
-
Lee, C.H.1
Olson, P.2
Hevener, A.3
Mehl, I.4
Chong, L.W.5
Olefsky, J.M.6
Gonzalez, F.J.7
Ham, J.8
Kang, H.9
Peters, J.M.10
Evans, R.M.11
-
37
-
-
13144281703
-
Identification of a gene encoding an acyl CoA: Diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis
-
Cases S, Smith SJ, Zheng YW, Myers HM, Lear SR, Sande E, Novak S, Collins C, Welch CB, Lusis AJ, et al: Identification of a gene encoding an acyl CoA: diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci USA 95: 13018-13023, 1998.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 13018-13023
-
-
Cases, S.1
Smith, S.J.2
Zheng, Y.W.3
Myers, H.M.4
Lear, S.R.5
Sande, E.6
Novak, S.7
Collins, C.8
Welch, C.B.9
Lusis, A.J.10
-
38
-
-
0036154857
-
Control of mitochondrial beta-oxidation flux
-
Eaton S: Control of mitochondrial beta-oxidation flux. Prog Lipid Res 41: 197-239, 2002.
-
(2002)
Prog Lipid Res
, vol.41
, pp. 197-239
-
-
Eaton, S.1
-
40
-
-
84898439031
-
Nonalcoholic fatty liver disease: Molecular mechanisms for the hepatic steatosis
-
Koo SH: Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. Clin Mol Hepatol 19: 210-215, 2013.
-
(2013)
Clin Mol Hepatol
, vol.19
, pp. 210-215
-
-
Koo, S.H.1
-
41
-
-
84859157277
-
Roles of PPARs in NAFLD: Potential therapeutic targets
-
Tailleux A, Wouters K and Staels B: Roles of PPARs in NAFLD: potential therapeutic targets. Biochim Biophys Acta 1821: 809-818, 2012.
-
(2012)
Biochim Biophys Acta
, vol.1821
, pp. 809-818
-
-
Tailleux, A.1
Wouters, K.2
Staels, B.3
-
42
-
-
84863104065
-
PPARs at the crossroads of lipid signaling and inflammation
-
Wahli W and Michalik L: PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol Metab 23: 351-363, 2012.
-
(2012)
Trends Endocrinol Metab
, vol.23
, pp. 351-363
-
-
Wahli, W.1
Michalik, L.2
-
43
-
-
84924653266
-
PPARbeta/delta prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism
-
Salvado L, Barroso E, Gomez-Foix AM, Palomer X, Michalik L, Wahli W and Vázquez-Carrera M: PPARbeta/delta prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism. Diabetologia 57: 2126-2135, 2014.
-
(2014)
Diabetologia
, vol.57
, pp. 2126-2135
-
-
Salvado, L.1
Barroso, E.2
Gomez-Foix, A.M.3
Palomer, X.4
Michalik, L.5
Wahli, W.6
Vázquez-Carrera, M.7
-
44
-
-
84901237355
-
PPARbeta/delta attenuates palmitate-induced endoplasmic reticulum stress and induces autophagic markers in human cardiac cells
-
Palomer X, Capdevila-Busquets E, Botteri G, Salvadó L, Barroso E, Davidson MM, Michalik L, Wahli W and Vázquez-Carrera M: PPARbeta/delta attenuates palmitate-induced endoplasmic reticulum stress and induces autophagic markers in human cardiac cells. Int J Cardiol 174: 110-118, 2014.
-
(2014)
Int J Cardiol
, vol.174
, pp. 110-118
-
-
Palomer, X.1
Capdevila-Busquets, E.2
Botteri, G.3
Salvadó, L.4
Barroso, E.5
Davidson, M.M.6
Michalik, L.7
Wahli, W.8
Vázquez-Carrera, M.9
-
45
-
-
84929503128
-
Activation of peroxisome proliferator activator receptor delta in mouse impacts lipid composition and placental development at early stage of gestation
-
Ding H, Zhang Y, Liu L, Yuan H, Qu J and Shen R: Activation of peroxisome proliferator activator receptor delta in mouse impacts lipid composition and placental development at early stage of gestation. Biol Reprod 91: 57, 2014.
-
(2014)
Biol Reprod
, vol.91
, pp. 57
-
-
Ding, H.1
Zhang, Y.2
Liu, L.3
Yuan, H.4
Qu, J.5
Shen, R.6
-
46
-
-
84862009920
-
Activation of PPARdelta up-regulates the expression of insulin gene transcription factor MafA and ameliorates glucose-induced insulin secretion impaired by palmitate
-
Cao M, Long Y, Tong Y, Wan J and Tong N: Activation of PPARdelta up-regulates the expression of insulin gene transcription factor MafA and ameliorates glucose-induced insulin secretion impaired by palmitate. Mol Cell Biochem 366: 183-189, 2012.
-
(2012)
Mol Cell Biochem
, vol.366
, pp. 183-189
-
-
Cao, M.1
Long, Y.2
Tong, Y.3
Wan, J.4
Tong, N.5
-
47
-
-
84905851448
-
Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma
-
Vacca M, D'Amore S, Graziano G, D?Orazio A, Cariello M, Massafra V, Salvatore L, Martelli N, Murzilli S, Lo Sasso G, et al: Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma. PLoS One 9: e104449, 2014.
-
(2014)
PLoS One
, vol.9
, pp. e104449
-
-
Vacca, M.1
D'Amore, S.2
Graziano, G.3
Dorazio, A.4
Cariello, M.5
Massafra, V.6
Salvatore, L.7
Martelli, N.8
Murzilli, S.9
Lo Sasso, G.10
-
48
-
-
84870946722
-
GW501516-activated PPARbeta/delta promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation
-
Kostadinova R, Montagner A, Gouranton E, Fleury S, Guillou H, Dombrowicz D, Desreumaux P and Wahli W: GW501516-activated PPARbeta/delta promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation. Cell Biosci 2: 34, 2012.
-
(2012)
Cell Biosci
, vol.2
, pp. 34
-
-
Kostadinova, R.1
Montagner, A.2
Gouranton, E.3
Fleury, S.4
Guillou, H.5
Dombrowicz, D.6
Desreumaux, P.7
Wahli, W.8
-
49
-
-
84924918447
-
Schistosoma japonicum soluble egg antigens facilitate hepatic stellate cell apoptosis by downregulating Akt expression and upregulating p53 and DR5 expression
-
Wang J, Xu F, Zhu D, Duan Y, Chen J, Sun X, He X, Li P, Sun W and Feng J: Schistosoma japonicum soluble egg antigens facilitate hepatic stellate cell apoptosis by downregulating Akt expression and upregulating p53 and DR5 expression. PLoS Negl Trop Dis 8: e3106, 2014.
-
(2014)
PLoS Negl Trop Dis
, vol.8
, pp. e3106
-
-
Wang, J.1
Xu, F.2
Zhu, D.3
Duan, Y.4
Chen, J.5
Sun, X.6
He, X.7
Li, P.8
Sun, W.9
Feng, J.10
-
50
-
-
84861437351
-
Protection from liver fibrosis by a peroxisome proliferator-activated receptor delta agonist
-
Iwaisako K, Haimerl M, Paik YH, Taura K, Kodama Y, Sirlin C, Yu E, Yu RT, Downes M, Evans RM, et al: Protection from liver fibrosis by a peroxisome proliferator-activated receptor delta agonist. Proc Natl Acad Sci USA 109: E1369-E1376, 2012.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, pp. E1369-E1376
-
-
Iwaisako, K.1
Haimerl, M.2
Paik, Y.H.3
Taura, K.4
Kodama, Y.5
Sirlin, C.6
Yu, E.7
Yu, R.T.8
Downes, M.9
Evans, R.M.10
-
51
-
-
84893146305
-
PPARdelta activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference
-
Feng YZ, Nikolic N, Bakke SS, Boekschoten MV, Kersten S, Kase ET, Rustan AC and Thoresen GH: PPARdelta activation in human myotubes increases mitochondrial fatty acid oxidative capacity and reduces glucose utilization by a switch in substrate preference. Arch Physiol Biochem 120: 12-21, 2014.
-
(2014)
Arch Physiol Biochem
, vol.120
, pp. 12-21
-
-
Feng, Y.Z.1
Nikolic, N.2
Bakke, S.S.3
Boekschoten, M.V.4
Kersten, S.5
Kase, E.T.6
Rustan, A.C.7
Thoresen, G.H.8
-
52
-
-
0035942162
-
A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
-
Oliver WR Jr, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA, Sznaidman ML, Lambert MH, et al: A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 98: 5306-5311, 2001.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 5306-5311
-
-
Oliver, W.R.1
Shenk, J.L.2
Snaith, M.R.3
Russell, C.S.4
Plunket, K.D.5
Bodkin, N.L.6
Lewis, M.C.7
Winegar, D.A.8
Sznaidman, M.L.9
Lambert, M.H.10
|